Medical Disorders
Basic InformationLookupsLatest News
Childhood Trauma Linked With Higher Odds for Adult Neurological IllsStudy Probes Relationship Between Migraines and SleepCancer in Hispanics: Good News and BadFDA Approves Pfizer Booster Shots for Seniors, High-Risk AmericansU.S. to Buy 500 Million More COVID Vaccine Doses for Global DonationAntibodies to Early Strains of COVID May Not Fight New Variants: StudyPregnant Women Who Get COVID Vaccine Pass Antibodies to NewbornsCDC Expert Panel to Weigh In on Vaccine BoostersWhich Kids Are at Highest Risk From COVID?4 Out of 10 Adults With No Known Heart Disease Have Fatty Hearts: StudyBooster Dose of J&J COVID Vaccine Increases ImmunityPost-Stroke Rehab: There's a Sweet Spot in the TimingCommon Form of Liver Cancer on the Rise in Rural AmericaCOVID Has Killed More Americans Than the Spanish Flu Did in 1918Telemedicine Gets High Marks for Follow-Ups After SurgeryPandemic Tied to Declining Birth Rates for U.S., Much of EuropeStudy Spots People at High Risk of Severe Breakthrough COVIDReview of Booster Shots for Moderna, J&J Vaccines Just Weeks Away: FauciDelta Variant Now Fueling 99% of U.S. COVID CasesLower Dose of Pfizer COVID Vaccine Works Well in Young Children, Company SaysFDA Panel OKs Pfizer Booster Shot for  People 65 or Older, But Not YoungerLong-Haul COVID in Kids Typically Ends Within 3 Months: StudyPfizer, Moderna Vaccines Still Offer Good Protection Against Severe COVID: StudyTrial Into Antioxidant for Parkinson's Disease Yields Disappointing ResultsIs Flu Ready for a Comeback? Get Your ShotDrug Might Stop Heart Trouble Linked to Sickle Cell AnemiaChild Obesity Rose Sharply During PandemicFDA Advisory Panel to Meet on COVID Booster ShotsStatin Cholesterol Drugs May Help Fight Ulcerative ColitisAHA News: Physical Activity Is Helpful After a Stroke, But How Much Is Healthy?Special 'Strategies' Can Help People With Parkinson's Walk, But Many Patients UnawareEven When Undergoing Treatment, People With MS Gain From COVID VaccinesNIH Spending Nearly $470 Million on Long-Haul COVID StudyHospitalizing the Unvaccinated Has Cost U.S. Nearly $6 BillionIn 16 States, 35% or More Residents Now Obese: CDCPet Store Puppies Passing Drug-Resistant Bacteria to PeopleIs a Combo COVID/Flu Shot on the Way?1 in 500 Americans Has Died From COVID-19Having Even a Cousin or Grandparent With Colon Cancer Raises Your Risk: StudyBlood Cancer Patients Could Benefit From COVID Booster Shot: StudyCOVID Vaccines for Kids Under 12 Could Come This Fall: FauciBritain OK's COVID Vaccine for Kids 12 and Older; Hopes to Avoid LockdownsCOVAX Cuts Global COVID Vaccine Supply Estimates By a QuarterMonth-Long Recovery From Concussion Is Normal: StudyDeath From COVID 11 Times More Likely If You're Unvaccinated: StudyL.A. Is First Major School District to Mandate Vaccines for Students 12 and UpNew Tally Adds Extra 16,000 U.S. Nursing Home Residents Lost to COVIDBlack Americans, Mexican Americans Develop Diabetes Earlier in LifeAverage COVID Hospitalization Is 150 Times More Expensive Than VaccinationGetting Your First COVID Shot Can Boost Mental Health: Study
Questions and AnswersVideosLinksBook Reviews
Related Topics

Men's Health
Women's Health

Which Cancer Patients Need a COVID Booster Shot Most?

HealthDay News
Updated: Sep 7th 2021

new article illustration

TUESDAY, Sept. 7, 2021 (HealthDay News) -- An alliance of leading U.S. cancer centers has updated guidance about COVID-19 vaccine boosters for cancer patients and the people around them.

The National Comprehensive Cancer Network's new recommendations are intended for health care providers.

"COVID-19 can be very dangerous, especially for people living with cancer, which is why we're so grateful for safe and effective vaccines that are saving lives," chief executive officer Dr. Robert Carlson said in a network news release.

The guidance, from the NCCN's Vaccination Advisory Committee, says several groups should be considered eligible immediately for a third dose of the Pfizer-BioNTech or Moderna mRNA COVID vaccine:

  • Patients with either new or recurring solid tumors receiving treatment within a year of their initial vaccine dose, regardless of their type of cancer therapy.
  • Patients with active blood cancers whether or not they are now receiving treatment.
  • Any cancer patient who received a stem cell transplant (SCT) or engineered cellular therapy (CAR T-cells), especially within the past two years.
  • Recipients of allogeneic SCT on immunosuppressive therapy or with a history of graft-versus-host disease regardless when they got their transplant.
  • Any cancer patients who also have an additional immunosuppressive condition -- such as HIV -- or are receiving immune-suppressing treatment unrelated to their cancer therapy.

The updated guidance is based on the latest information from the U.S. Food and Drug Administration and U.S. Centers for Disease Control and Prevention.

It highlights CDC recommendations for people to wait at least four weeks between second and third doses. Patients who develop COVID-19 despite having two doses should wait for their third dose until they have confirmed they are no longer infected.

People who live with immunocompromised people should also get a third dose once it is available to them, the committee advised.

The advisory said it's best for that third dose to be the same type of vaccine as the first two doses, but a different mRNA vaccine is also acceptable. In other words, someone who had the Pfizer vaccine could get a Moderna booster, and vice versa.

If possible, immunocompromised people should to try to receive their third dose in a health care setting instead of a pharmacy or public vaccination clinic to limit their risk of exposure to the general population.

"When it comes to people's safety, we have to take every precaution," said Dr. Steve Pergam, co-leader of the advisory committee.

"That means even after a third dose of vaccine, we still recommend immunocompromised people -- such as those undergoing cancer treatment -- continue to be cautious, wear masks and avoid large group gatherings, particularly around those who are unvaccinated," Pergam said in the release.

The recommendation did not address the single-shot Johnson & Johnson vaccine, which is not an mRNA vaccine.

More information

The American Cancer Society has more on COVID-19.

SOURCE: National Comprehensive Cancer Network, news release, Aug. 30, 2021


Amazon Smile


Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.


powered by centersite dot net